Mayo Clinic-backed Pendulum near doubled its total funding in a round that will support increased manufacturing of its lead probiotic product.
Pendulum Therapeutics, a US-based microbiome-focused medical product developer backed by medical research and care provider Mayo Clinic, has received $54m in a series C round led by Meritech Capital.
Meritech was joined by existing investors including fellow venture capital firms Sequoia Capital, True Ventures and Khosla Ventures. Craig Sherman, a general partner at Meritech, is joining Pendulum’s board of directors in connection with the round.
Formerly known as Whole Biome before rebranding in September 2019, Pendulum provides products tailored to…
